Antibiotic Bootcamps for Developers: What Makes a Good Project Succeed?

ASM/ESCMID Joint Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance

8-9 December 2021, Online

Collaboratively organized by GARDP, CARB-X, REPAIR Impact Fund and JPIAMR


  • Ursula Theuretzbacher, Center for Anti-Infective Agents, Austria
  • Sumathi Nambiar, Johnson & Johnson, USA


  • Lloyd Czaplewski, Chemical Biology Ventures Ltd, UK
  • David Melnick, Spero Therapeutics, USA
  • Subasree Srinivasan, Global Antibiotic R&D Partnership (GARDP), USA

  1. Introductions
  2. What is Needed to Build an Attractive Discovery and Preclinical Project? (Lloyd Czaplewski)
  3. How to integrate a demonstration of value to patients into pivotal trials (David Melnick)
  4. Demonstrating public health value (Subasree Srinivasan)
  5. Q& A and Open Discussion

Jointly organized by: